ARTICLE | Distillery Therapeutics
Therapeutics: Tissue inhibitor of metalloproteinases 1 (TIMP1)
January 28, 2016 8:00 AM UTC
In vitro and mouse studies suggest inhibiting TIMP1 could help treat glioblastoma multiforme (GBM). In GBM patients, low TIMP1 expression in tumors correlated with overall survival. In a mouse model o...